Valeo Financial Advisors LLC Purchases 4,512 Shares of Oracle Corporation $ORCL

Valeo Financial Advisors LLC grew its position in Oracle Corporation (NYSE:ORCL) by 5.0% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 95,299 shares of the enterprise software provider’s stock after buying an additional 4,512 shares during the period. Valeo Financial Advisors LLC’s holdings in Oracle were worth $20,835,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in ORCL. Brighton Jones LLC raised its holdings in Oracle by 189.3% during the 4th quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider’s stock worth $25,593,000 after purchasing an additional 100,494 shares during the last quarter. Revolve Wealth Partners LLC boosted its stake in shares of Oracle by 8.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider’s stock valued at $903,000 after purchasing an additional 404 shares during the last quarter. Steward Partners Investment Advisory LLC grew its position in shares of Oracle by 3.2% during the 1st quarter. Steward Partners Investment Advisory LLC now owns 227,463 shares of the enterprise software provider’s stock worth $31,802,000 after buying an additional 7,057 shares during the period. LeConte Wealth Management LLC bought a new stake in shares of Oracle during the first quarter worth approximately $233,000. Finally, Seven Mile Advisory lifted its holdings in Oracle by 5.7% in the first quarter. Seven Mile Advisory now owns 6,108 shares of the enterprise software provider’s stock valued at $854,000 after buying an additional 331 shares during the period. Institutional investors and hedge funds own 42.44% of the company’s stock.

Insiders Place Their Bets

In other Oracle news, Director Jeffrey Berg sold 49,365 shares of Oracle stock in a transaction dated Tuesday, October 28th. The stock was sold at an average price of $283.02, for a total value of $13,971,282.30. Following the sale, the director owned 151,999 shares of the company’s stock, valued at $43,018,756.98. This trade represents a 24.52% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Naomi O. Seligman sold 2,222 shares of the company’s stock in a transaction dated Friday, September 26th. The stock was sold at an average price of $288.91, for a total value of $641,958.02. Following the transaction, the director directly owned 29,225 shares of the company’s stock, valued at $8,443,394.75. This represents a 7.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 171,513 shares of company stock worth $50,397,893 in the last ninety days. 40.90% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of analysts have commented on ORCL shares. TD Cowen lowered their target price on shares of Oracle from $400.00 to $350.00 and set a “buy” rating for the company in a report on Thursday. BNP Paribas set a $377.00 price objective on Oracle in a research note on Wednesday, September 10th. Scotiabank dropped their price objective on Oracle from $360.00 to $260.00 and set a “sector outperform” rating for the company in a report on Thursday. Jefferies Financial Group raised their target price on Oracle from $360.00 to $400.00 and gave the stock a “buy” rating in a report on Friday, October 17th. Finally, Sanford C. Bernstein lowered their price target on Oracle from $364.00 to $339.00 and set an “outperform” rating for the company in a research note on Thursday. Three equities research analysts have rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating, twelve have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $301.57.

Oracle Trading Down 4.6%

NYSE:ORCL opened at $189.64 on Monday. The company has a debt-to-equity ratio of 3.28, a current ratio of 0.91 and a quick ratio of 0.91. The business’s 50-day simple moving average is $245.58 and its 200-day simple moving average is $241.93. Oracle Corporation has a fifty-two week low of $118.86 and a fifty-two week high of $345.72. The stock has a market capitalization of $544.86 billion, a PE ratio of 35.65, a price-to-earnings-growth ratio of 1.82 and a beta of 1.66.

Oracle (NYSE:ORCL) last posted its earnings results on Wednesday, December 10th. The enterprise software provider reported $2.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.64 by $0.62. Oracle had a return on equity of 70.60% and a net margin of 25.28%.The business had revenue of $16.06 billion during the quarter, compared to analysts’ expectations of $16.19 billion. During the same period in the prior year, the business earned $1.47 EPS. Oracle’s revenue for the quarter was up 14.2% compared to the same quarter last year. Sell-side analysts expect that Oracle Corporation will post 5 earnings per share for the current fiscal year.

Oracle Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 23rd. Investors of record on Friday, January 9th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Friday, January 9th. Oracle’s dividend payout ratio (DPR) is presently 37.59%.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.